Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trial
Top Cited Papers
- 10 March 2018
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 200, 44-50
- https://doi.org/10.1016/j.ahj.2018.03.008
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trialThe Lancet, 2013
- Comparison of Complications and Outcomes to One Year of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic StenosisThe American Journal of Cardiology, 2012
- Dual Antiplatelet Therapy Versus Aspirin Alone in Patients Undergoing Transcatheter Aortic Valve ImplantationThe American Journal of Cardiology, 2011
- Apixaban versus Warfarin in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- Standardized Bleeding Definitions for Cardiovascular Clinical TrialsCirculation, 2011
- Apixaban in Patients with Atrial FibrillationThe New England Journal of Medicine, 2011
- Incidence and Predictors of Early and Late Mortality After Transcatheter Aortic Valve Implantation in 663 Patients With Severe Aortic StenosisCirculation, 2011
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo SurgeryThe New England Journal of Medicine, 2010
- ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary interventionEuropean Heart Journal, 2010
- Idraparinux versus Standard Therapy for Venous Thromboembolic DiseaseThe New England Journal of Medicine, 2007